Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 28

1.

A direct comparison of human papillomavirus type 16 L1 particles reveals a lower immunogenicity of capsomeres than viruslike particles with respect to the induced antibody response.

Thönes N, Herreiner A, Schädlich L, Piuko K, Müller M.

J Virol. 2008 Jun;82(11):5472-85. doi: 10.1128/JVI.02482-07. Epub 2008 Apr 2.

PMID:
18385253
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Characterization of the epitope for anti-human respiratory syncytial virus F protein monoclonal antibody 101F using synthetic peptides and genetic approaches.

Wu SJ, Schmidt A, Beil EJ, Day ND, Branigan PJ, Liu C, Gutshall LL, Palomo C, Furze J, Taylor G, Melero JA, Tsui P, Del Vecchio AM, Kruszynski M.

J Gen Virol. 2007 Oct;88(Pt 10):2719-23.

PMID:
17872524
[PubMed - indexed for MEDLINE]
Free Article
3.

Virus-like particles: flexible platforms for vaccine development.

Chackerian B.

Expert Rev Vaccines. 2007 Jun;6(3):381-90. Review.

PMID:
17542753
[PubMed - indexed for MEDLINE]
4.

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.

Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, Tang GW, Ferris DG, Steben M, Bryan J, Taddeo FJ, Railkar R, Esser MT, Sings HL, Nelson M, Boslego J, Sattler C, Barr E, Koutsky LA; Females United to Unilaterally Reduce Endo/Ectocervical Disease (FUTURE) I Investigators.

N Engl J Med. 2007 May 10;356(19):1928-43.

PMID:
17494926
[PubMed - indexed for MEDLINE]
Free Article
5.

Deletion of a major neutralizing epitope of human papillomavirus type 16 virus-like particles.

Ryding J, Dahlberg L, Wallen-Ohman M, Dillner J.

J Gen Virol. 2007 Mar;88(Pt 3):792-802.

PMID:
17325351
[PubMed - indexed for MEDLINE]
Free Article
6.

Structure-based engineering of papillomavirus major capsid l1: controlling particle assembly.

Bishop B, Dasgupta J, Chen XS.

Virol J. 2007 Jan 8;4:3.

PMID:
17210082
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16.

Varsani A, Williamson AL, de Villiers D, Becker I, Christensen ND, Rybicki EP.

J Virol. 2003 Aug;77(15):8386-93.

PMID:
12857908
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

A controlled trial of a human papillomavirus type 16 vaccine.

Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, Chiacchierini LM, Jansen KU; Proof of Principle Study Investigators.

N Engl J Med. 2002 Nov 21;347(21):1645-51.

PMID:
12444178
[PubMed - indexed for MEDLINE]
Free Article
9.

Atomic model of the papillomavirus capsid.

Modis Y, Trus BL, Harrison SC.

EMBO J. 2002 Sep 16;21(18):4754-62.

PMID:
12234916
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Chimeric papillomavirus-like particles expressing a foreign epitope on capsid surface loops.

Slupetzky K, Shafti-Keramat S, Lenz P, Brandt S, Grassauer A, Sara M, Kirnbauer R.

J Gen Virol. 2001 Nov;82(Pt 11):2799-804.

PMID:
11602792
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Immunization with a pentameric L1 fusion protein protects against papillomavirus infection.

Yuan H, Estes PA, Chen Y, Newsome J, Olcese VA, Garcea RL, Schlegel R.

J Virol. 2001 Sep;75(17):7848-53.

PMID:
11483728
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Induction of type-specific neutralizing antibodies by capsomeres of human papillomavirus type 33.

Fligge C, Giroglou T, Streeck RE, Sapp M.

Virology. 2001 May 10;283(2):353-7.

PMID:
11336560
[PubMed - indexed for MEDLINE]
Free Article
13.

A Phase 1 study of a recombinant viruslike particle vaccine against human papillomavirus type 11 in healthy adult volunteers.

Evans TG, Bonnez W, Rose RC, Koenig S, Demeter L, Suzich JA, O'Brien D, Campbell M, White WI, Balsley J, Reichman RC.

J Infect Dis. 2001 May 15;183(10):1485-93. Epub 2001 Apr 24.

PMID:
11319684
[PubMed - indexed for MEDLINE]
Free Article
14.

Papillomavirus capsid protein expression in Escherichia coli: purification and assembly of HPV11 and HPV16 L1.

Chen XS, Casini G, Harrison SC, Garcea RL.

J Mol Biol. 2001 Mar 16;307(1):173-82.

PMID:
11243812
[PubMed - indexed for MEDLINE]
15.

Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16.

Chen XS, Garcea RL, Goldberg I, Casini G, Harrison SC.

Mol Cell. 2000 Mar;5(3):557-67.

PMID:
10882140
[PubMed - indexed for MEDLINE]
Free Article
16.

Induction of autoantibodies to mouse CCR5 with recombinant papillomavirus particles.

Chackerian B, Lowy DR, Schiller JT.

Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2373-8.

PMID:
10051649
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Antigenic structure of human respiratory syncytial virus fusion glycoprotein.

López JA, Bustos R, Orvell C, Berois M, Arbiza J, García-Barreno B, Melero JA.

J Virol. 1998 Aug;72(8):6922-8.

PMID:
9658147
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Human papillomavirus type 11 recombinant L1 capsomeres induce virus-neutralizing antibodies.

Rose RC, White WI, Li M, Suzich JA, Lane C, Garcea RL.

J Virol. 1998 Jul;72(7):6151-4.

PMID:
9621080
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Quantitative disassembly and reassembly of human papillomavirus type 11 viruslike particles in vitro.

McCarthy MP, White WI, Palmer-Hill F, Koenig S, Suzich JA.

J Virol. 1998 Jan;72(1):32-41.

PMID:
9420197
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk